| 1 | Oophoritis | 40.5% |
| 2 | Ovarian Hyperstimulation Syndrome | 39.1% |
| 3 | Anovulation | 32.4% |
| 4 | ovarian neoplasm | 31.5% |
| 5 | granulosa cell tumor | 22.2% |
| 6 | Carcinoma, Ovarian Epithelial | 22.2% |
| 7 | Carcinoma, Endometrioid | 20.9% |
| 8 | Follicular cyst | 20.4% |
| 9 | Mucocele | 20.4% |
| 10 | Pilonidal Cyst | 20.4% |
| 11 | Thyroglossal Cyst | 20.4% |
| 12 | Synovial Cyst | 20.4% |
| 13 | Salpingitis | 19.7% |
| 14 | Dermoid Cyst | 19.5% |
| 15 | Premature Menopause | 16.9% |
| 16 | Endometritis | 16.8% |
| 17 | Lymphocele | 16.5% |
| 18 | Pancreatic Cyst | 16.5% |
| 19 | Breast Cyst | 16.3% |
| 20 | Mediastinal Cyst | 16.3% |
| 21 | Parovarian Cyst | 16.3% |
| 22 | Pericardial Cyst | 16.3% |
| 23 | Thymic Cyst | 16.3% |
| 24 | Myxoid cyst | 16.3% |
| 25 | Hypogonadism | 15.3% |
| 26 | Delayed Puberty | 15.3% |
| 27 | Precocious Puberty | 15.3% |
| 28 | Hypogonadotropic hypogonadism | 15.3% |
| 29 | Testotoxicosis | 15.3% |
| 30 | Adnexitis | 15% |
| 31 | Pelvic Inflammatory Disease | 15% |
| 32 | Endometriosis | 14.6% |
| 33 | Uterine Diseases | 14.6% |
| 34 | Vaginal Diseases | 14.6% |
| 35 | Vulvar Diseases | 14.6% |
| 36 | Endometrioma | 14.6% |
| 37 | Fallopian Tube Neoplasms | 13.4% |
| 38 | Endocrine Gland Neoplasms | 12.7% |
| 39 | Hermaphroditism | 12.4% |
| 40 | Disorders of Sex Development | 12.4% |
| 41 | Parametritis | 12.4% |
| 42 | Testicular Diseases | 12.4% |
| 43 | Pancreatic Pseudocyst | 12% |
| 44 | Multiple Endocrine Neoplasia | 12% |
| 45 | Infertility | 11.9% |
| 46 | Choledochal Cyst | 11.7% |
| 47 | Parathyroid Neoplasms | 11.7% |
| 48 | Thyroid Neoplasm | 11.7% |
| 49 | Thyroid carcinoma | 11.7% |
| 50 | Pregnancy Complications, Neoplastic | 11.7% |
| 51 | Uterine Neoplasms | 11% |
| 52 | Vaginal Neoplasms | 11% |
| 53 | Vulvar Neoplasms | 11% |
| 54 | Uterine Cancer | 11% |
| 55 | Testicular Neoplasms | 10.8% |
| 56 | Hamartoma | 10.6% |
| 57 | Neoplasms, Hormone-Dependent | 10.6% |
| 58 | Neoplasms, Multiple Primary | 10.6% |
| 59 | Paraneoplastic Syndromes | 10.6% |
| 60 | Precancerous Conditions | 10.6% |
| 61 | Neoplasms, Second Primary | 10.6% |
| 62 | Adrenal Gland Neoplasms | 10.3% |
| 63 | Carcinoma 256, Walker | 9.7% |
| 64 | Urologic Diseases | 9.5% |
| 65 | Medulloblastoma | 9.3% |
| 66 | Trophoblastic Neoplasms | 9.3% |
| 67 | Vulvovaginitis | 9.2% |
| 68 | Genital Neoplasms, Female | 9% |
| 69 | Melanoma, Experimental | 8.8% |
| 70 | Neoplasms, Neuroepithelial | 8.8% |
| 71 | Gliomatosis cerebri | 8.8% |
| 72 | Adrenal Gland Diseases | 8.8% |
| 73 | Parathyroid Diseases | 8.8% |
| 74 | Thyroid Diseases | 8.8% |
| 75 | Kallmann Syndrome | 8.8% |
| 76 | Sexually Transmitted Diseases | 8.8% |
| 77 | Carcinoma, Ehrlich Tumor | 8.8% |
| 78 | Carcinoma, Lewis Lung | 8.8% |
| 79 | Endometrial Hyperplasia | 8.7% |
| 80 | Pyometra | 8.7% |
| 81 | Vaginitis | 8.7% |
| 82 | Vulvitis | 8.7% |
| 83 | Vaginal Discharge | 8.7% |
| 84 | Vulvodynia | 8.7% |
| 85 | Multiple Endocrine Neoplasia Type 1 | 8.7% |
| 86 | Uterine Inversion | 8.6% |
| 87 | Thyroid Nodule | 8.5% |
| 88 | Neoplastic Processes | 8.5% |
| 89 | Neoplastic Syndromes, Hereditary | 8.5% |
| 90 | Genital Herpes | 8.4% |
| 91 | Basal Cell Nevus Syndrome | 8.4% |
| 92 | Neoplasms, Experimental | 8.4% |
| 93 | melanoma | 8.2% |
| 94 | Orchitis | 8% |
| 95 | Neuroectodermal Tumors | 8% |
| 96 | Choriocarcinoma | 8% |
| 97 | Paraneoplastic Encephalomyelitis | 8% |
| 98 | Urogenital Abnormalities | 8% |
| 99 | Endometrial Neoplasms | 7.9% |
| 100 | Leukemia, Experimental | 7.8% |
| 101 | Mammary Neoplasms, Experimental | 7.8% |
| 102 | Klinefelter Syndrome | 7.8% |
| 103 | Gonadal Dysgenesis | 7.8% |
| 104 | Adrenogenital Syndrome | 7.8% |
| 105 | Ovotesticular Disorders of Sex Development | 7.8% |
| 106 | Endometrial Stromal Sarcoma | 7.8% |
| 107 | Meningioma | 7.8% |
| 108 | Pancreatic Neoplasm | 7.7% |
| 109 | Leydig Cell Tumor | 7.7% |
| 110 | Adenoma, Acidophil | 7.6% |
| 111 | Ganglioneuroma | 7.6% |
| 112 | Glioma | 7.6% |
| 113 | Malignant Glioma | 7.6% |
| 114 | Urologic Neoplasms | 7.6% |
| 115 | Pregnancy Complications | 7.5% |
| 116 | Carcinoma, Pancreatic Ductal | 7.5% |
| 117 | Prolactinoma | 7.4% |
| 118 | Growth Hormone-Secreting Pituitary Adenoma | 7.4% |
| 119 | Carcinoid Tumor | 7.3% |
| 120 | Neurilemmoma | 7.3% |
| 121 | Hutchinson's Melanotic Freckle | 7.3% |
| 122 | Melanoma, Amelanotic | 7.3% |
| 123 | Nephroblastoma | 7.3% |
| 124 | Adrenocortical carcinoma | 7.3% |
| 125 | Carcinosarcoma | 7.3% |
| 126 | Hemangiosarcoma | 7.3% |
| 127 | Leukemia L1210 | 7.3% |
| 128 | Leukemia P388 | 7.3% |
| 129 | lymphangiosarcoma | 7.3% |
| 130 | Acanthoma | 7.3% |
| 131 | Uterine Rupture | 7.3% |
| 132 | Carcinoma, Lobular | 7.3% |
| 133 | Sarcoma, Experimental | 7.2% |
| 134 | Hyperandrogenism | 7.1% |
| 135 | Bone Diseases, Endocrine | 7.1% |
| 136 | Astrocytoma | 7% |
| 137 | Ependymoma | 7% |
| 138 | oligodendroglioma | 7% |
| 139 | Ganglioglioma | 7% |
| 140 | gliosarcoma | 7% |
| 141 | Anaplastic astrocytoma | 7% |
| 142 | Anaplastic Oligodendroglioma | 7% |
| 143 | Pruritus Vulvae | 7% |
| 144 | Uterine hemorrhage | 7% |
| 145 | Vaginal Fistula | 7% |
| 146 | Diabetes Mellitus | 7% |
| 147 | Neoplasms, Radiation-Induced | 7% |
| 148 | Sarcoma 180 | 7% |
| 149 | Uterine Prolapse | 6.9% |
| 150 | Vaginal Prolapse | 6.9% |
| 151 | Pituitary Diseases | 6.9% |
| 152 | Malignant Carcinoid Syndrome | 6.9% |
| 153 | Denys-Drash Syndrome | 6.8% |
| 154 | Abdominal Neoplasms | 6.8% |
| 155 | Erythroplasia | 6.8% |
| 156 | Head and Neck Neoplasms | 6.8% |
| 157 | leukemia | 6.8% |
| 158 | Neoplasms, Germ Cell and Embryonal | 6.8% |
| 159 | Neoplasms, Glandular and Epithelial | 6.8% |
| 160 | Soft Tissue Neoplasms | 6.8% |
| 161 | Thoracic Neoplasms | 6.8% |
| 162 | Germ Cell Cancer | 6.8% |
| 163 | Aberrant Crypt Foci | 6.8% |
| 164 | Leukemia, Radiation-Induced | 6.8% |
| 165 | Tuberous Sclerosis | 6.8% |
| 166 | Glioblastoma | 6.8% |
| 167 | Neuroblastoma | 6.8% |
| 168 | Glioblastoma Multiforme | 6.8% |
| 169 | Vipoma | 6.6% |
| 170 | Pituitary Adenoma | 6.6% |
| 171 | Pituitary Neoplasms | 6.6% |
| 172 | Ganglioneuroblastoma | 6.6% |
| 173 | Basal cell carcinoma | 6.6% |
| 174 | Carcinoma, Papillary | 6.6% |
| 175 | Squamous cell carcinoma | 6.6% |
| 176 | Chondrosarcoma | 6.6% |
| 177 | Craniopharyngioma | 6.6% |
| 178 | Cystadenoma | 6.6% |
| 179 | leiomyosarcoma | 6.6% |
| 180 | liposarcoma | 6.6% |
| 181 | Mesothelioma | 6.6% |
| 182 | synovial sarcoma | 6.6% |
| 183 | Neuroectodermal Tumor, Melanotic | 6.6% |
| 184 | Angiomyolipoma | 6.6% |
| 185 | Clear Cell Sarcoma of Soft Tissue | 6.6% |
| 186 | Alveolar Soft Part Sarcoma | 6.6% |
| 187 | Neuroendocrine Tumors | 6.6% |
| 188 | Sarcoma, Myeloid | 6.6% |
| 189 | Carcinoma, Basal Cell | 6.6% |
| 190 | Retinoblastoma | 6.3% |
| 191 | Cystadenocarcinoma | 6.2% |
| 192 | Fibrosarcoma | 6.2% |
| 193 | Osteosarcoma | 6.2% |
| 194 | Mucoepidermoid Carcinoma | 6.2% |
| 195 | Thymoma | 6.1% |
| 196 | Adenofibroma | 6.1% |
| 197 | Fibroadenoma | 6.1% |
| 198 | Malignant Fibrous Histiocytoma | 6.1% |
| 199 | Acoustic Neuroma | 6.1% |
| 200 | Leukemia, Plasma Cell | 6.1% |
| 201 | Mesoblastic Nephroma | 6% |
| 202 | insulinoma | 6% |
| 203 | Gestational Diabetes | 5.9% |
| 204 | Bowen's Disease | 5.9% |
| 205 | Paraganglioma | 5.9% |
| 206 | Rhabdomyosarcoma | 5.9% |
| 207 | Giant Cell Tumor of Bone | 5.9% |
| 208 | Diabetes Insipidus | 5.9% |
| 209 | Lymphomatoid Granulomatosis | 5.9% |
| 210 | Dyspareunia | 5.9% |
| 211 | Gastrinoma | 5.9% |
| 212 | Glucagonoma | 5.9% |
| 213 | Peritoneal Neoplasms | 5.8% |
| 214 | Dwarfism | 5.8% |
| 215 | Carcinoid Heart Disease | 5.8% |
| 216 | Uterine Cervicitis | 5.8% |
| 217 | Leukorrhea | 5.8% |
| 218 | Cryptorchidism | 5.8% |
| 219 | Bladder Neoplasm | 5.8% |
| 220 | Kidney Neoplasm | 5.8% |
| 221 | Ureteral Neoplasms | 5.8% |
| 222 | Urethral Neoplasms | 5.8% |
| 223 | Candidiasis, Vulvovaginal | 5.7% |
| 224 | Dermatofibrosarcoma | 5.7% |
| 225 | Dermatofibrosarcoma Protuberans | 5.7% |
| 226 | Hydatidiform Mole | 5.7% |
| 227 | Composite Lymphoma | 5.7% |
| 228 | Digestive System Neoplasms | 5.7% |
| 229 | Eye Neoplasms | 5.7% |
| 230 | Nervous System Neoplasms | 5.7% |
| 231 | Uterine Cervical Incompetence | 5.6% |
| 232 | Pheochromocytoma | 5.6% |
| 233 | Alveolar rhabdomyosarcoma | 5.6% |
| 234 | Bone neoplasms | 5.5% |
| 235 | Leukoplakia | 5.5% |
| 236 | Skin Neoplasms | 5.5% |
| 237 | Hematologic Neoplasms | 5.5% |
| 238 | Liver Neoplasms, Experimental | 5.4% |
| 239 | Barrett Esophagus | 5.4% |
| 240 | Histiocytic Disorders, Malignant | 5.4% |
| 241 | Actinic keratosis | 5.4% |
| 242 | Neoplasm Invasiveness | 5.4% |
| 243 | Neoplasm Metastasis | 5.4% |
| 244 | Neoplasm Recurrence, Local | 5.4% |
| 245 | Splenic Neoplasms | 5.4% |
| 246 | Carcinogenesis | 5.4% |
| 247 | Metastasis | 5.4% |
| 248 | Optic Nerve Glioma | 5.4% |
| 249 | Renal Cell Carcinoma | 5.4% |
| 250 | Papillary Renal Cell Carcinoma | 5.4% |
| 251 | Neurofibrosarcoma | 5.4% |
| 252 | Tracheal Neoplasms | 5.3% |
| 253 | Vesicovaginal Fistula | 5.3% |
| 254 | Leukoplakia, Oral | 5.2% |
| 255 | Paraneoplastic Cerebellar Degeneration | 5.2% |
| 256 | Radicular Cyst | 5.2% |
| 257 | Adrenal Cortex Diseases | 5.1% |
| 258 | Euthyroid Sick Syndromes | 5.1% |
| 259 | Goiter | 5.1% |
| 260 | Hyperparathyroidism | 5.1% |
| 261 | Hyperthyroidism | 5.1% |
| 262 | Hyperthyroxinemia | 5.1% |
| 263 | Hypoparathyroidism | 5.1% |
| 264 | Hypothyroidism | 5.1% |
| 265 | Thyroiditis | 5.1% |
| 266 | Secondary hypothyroidism | 5.1% |
| 267 | Primary Hyperthyroidism | 5.1% |
| 268 | Primary Hypothyroidism | 5.1% |
| 269 | Urinary Bladder Diseases | 5.1% |
| 270 | Kidney Diseases | 5.1% |
| 271 | Ureteral Diseases | 5.1% |
| 272 | Urethral Diseases | 5.1% |
| 273 | Urination Disorders | 5.1% |
| 274 | Urolithiasis | 5.1% |
| 275 | Bladder Exstrophy | 5% |
| 276 | Epispadias | 5% |
| 277 | Adenoma | 5% |
| 278 | Ameloblastoma | 5% |
| 279 | Angiokeratoma | 5% |
| 280 | Carcinoma | 5% |
| 281 | Chordoma | 5% |
| 282 | Hemangioma | 5% |
| 283 | hemangiopericytoma | 5% |
| 284 | Lymphangioma | 5% |
| 285 | Mesenchymoma | 5% |
| 286 | Nevus | 5% |
| 287 | Retroperitoneal Neoplasms | 5% |
| 288 | Teratoma | 5% |
| 289 | Hepatoblastoma | 5% |
| 290 | Mixed Tumor, Mullerian | 5% |
| 291 | Germinoma | 5% |
| 292 | Teratocarcinoma | 5% |
| 293 | Angiofibroma | 5% |
| 294 | Sarcoma | 5% |
| 295 | Epithelioma | 5% |
| 296 | Tuberculosis, Renal | 5% |
| 297 | Nelson Syndrome | 4.9% |
| 298 | Turner Syndrome | 4.9% |
| 299 | Hepatocellular Adenoma | 4.7% |
| 300 | Diabetic Nephropathy | 4.7% |
| 301 | Bacterial Vaginosis | 4.7% |
| 302 | Lymphangioleiomyomatosis | 4.7% |
| 303 | Trichomonas Vaginitis | 4.6% |
| 304 | Uterine Perforation | 4.6% |
| 305 | Metrorrhagia | 4.6% |
| 306 | Esophageal Neoplasms | 4.6% |
| 307 | Adenomatous Polyposis Coli | 4.6% |
| 308 | Limbic Encephalitis | 4.5% |
| 309 | Lymphoma | 4.5% |
| 310 | Multicystic Dysplastic Kidney | 4.4% |
| 311 | Urinary tract infection | 4.3% |
| 312 | Anuria | 4.3% |
| 313 | Ureterolithiasis | 4.3% |
| 314 | Nephrolithiasis | 4.3% |
| 315 | Horseshoe Kidney | 4.2% |
| 316 | Congenital Hypothyroidism | 4.2% |
| 317 | Adenocarcinoma | 4.1% |
| 318 | Carcinoma in Situ | 4.1% |
| 319 | Carcinoma, Transitional Cell | 4.1% |
| 320 | Phyllodes Tumor | 4.1% |
| 321 | Dysgerminoma | 4.1% |
| 322 | Hemangioendothelioma | 4.1% |
| 323 | Lipoma | 4.1% |
| 324 | Myoma | 4.1% |
| 325 | Myxoma | 4.1% |
| 326 | Neuroma | 4.1% |
| 327 | Papilloma | 4.1% |
| 328 | Pseudomyxoma Peritonei | 4.1% |
| 329 | Seminoma | 4.1% |
| 330 | Papillomatosis | 4.1% |
| 331 | Angiolipoma | 4.1% |
| 332 | Myelolipoma | 4.1% |
| 333 | Neoplasms, Bone Tissue | 4.1% |
| 334 | Neoplasms, Fibrous Tissue | 4.1% |
| 335 | Smooth Muscle Tumor | 4.1% |
| 336 | Adenomatosis, Pulmonary | 4.1% |
| 337 | Adenomatous Polyps | 4.1% |
| 338 | Carcinoma, Large Cell | 4.1% |
| 339 | Carcinoma, Small Cell | 4.1% |
| 340 | Desmoplastic Small Round Cell Tumor | 4.1% |
| 341 | Chondroma | 4.1% |
| 342 | Enchondroma | 4.1% |
| 343 | Lambert-Eaton Myasthenic Syndrome | 4.1% |
| 344 | Mouth Neoplasms | 4.1% |
| 345 | Central Nervous System Neoplasms | 4.1% |
| 346 | Vascular Neoplasms | 4.1% |
| 347 | Thymus Neoplasms | 4.1% |
| 348 | Empty Sella Syndrome | 4% |
| 349 | Hyperpituitarism | 4% |
| 350 | Hypopituitarism | 4% |
| 351 | Hypophysitis | 4% |
| 352 | Plasmacytoma | 4% |
| 353 | Malignant histiocytosis | 4% |
| 354 | Lymphatic Metastasis | 4% |
| 355 | Neoplasms, Unknown Primary | 4% |
| 356 | Leukemic Infiltration | 4% |
| 357 | Breast Neoplasms, Male | 4% |
| 358 | Histiocytic sarcoma | 4% |
| 359 | Neoplasm Micrometastasis | 4% |
| 360 | Triple Negative Breast Neoplasms | 4% |
| 361 | Graves Disease | 3.9% |
| 362 | Menorrhagia | 3.8% |
| 363 | Polyhydramnios | 3.8% |
| 364 | Obstetric Labor Complications | 3.8% |
| 365 | Ectopic Pregnancy | 3.8% |
| 366 | Pregnancy, Prolonged | 3.8% |
| 367 | Puerperal Disorders | 3.8% |
| 368 | Oligohydramnios | 3.8% |
| 369 | Prenatal Injuries | 3.8% |
| 370 | Peutz-Jeghers Syndrome | 3.8% |
| 371 | Adenoid Cystic Carcinoma | 3.7% |
| 372 | fibroma | 3.7% |
| 373 | Fibromatosis | 3.7% |
| 374 | Osteoblastoma | 3.7% |
| 375 | Osteoma | 3.7% |
| 376 | Rhabdomyoma | 3.7% |
| 377 | Chondromatosis | 3.7% |
| 378 | Adenocarcinoma, Clear Cell | 3.7% |
| 379 | Cholangiocarcinoma | 3.7% |
| 380 | Cervical Intraepithelial Neoplasia | 3.7% |
| 381 | Hemangioblastoma | 3.7% |
| 382 | Lymphoma, Extranodal NK-T-Cell | 3.7% |
| 383 | Urinary Bladder Fistula | 3.7% |
| 384 | Opsoclonus-Myoclonus Syndrome | 3.7% |
| 385 | Hypospadias | 3.6% |
| 386 | Bladder neck obstruction | 3.5% |
| 387 | Fibromatosis, Aggressive | 3.5% |
| 388 | Fibromatosis, Abdominal | 3.5% |
| 389 | Klatskin Tumor | 3.5% |
| 390 | Palatal Neoplasms | 3.5% |
| 391 | Gastrointestinal Neoplasms | 3.4% |
| 392 | Genital Neoplasms, Male | 3.4% |
| 393 | Liver neoplasms | 3.4% |
| 394 | Uveal Neoplasms | 3.4% |
| 395 | Latent Autoimmune Diabetes in Adults | 3.4% |
| 396 | Nose Neoplasms | 3.4% |
| 397 | Diabetes Mellitus, Experimental | 3.4% |
| 398 | Cushing Syndrome | 3.3% |
| 399 | Hyperaldosteronism | 3.3% |
| 400 | Hyperparathyroidism, Secondary | 3.3% |
| 401 | Hypoaldosteronism | 3.3% |
| 402 | Thyrotoxicosis | 3.3% |
| 403 | Hyperparathyroidism, Primary | 3.3% |
| 404 | Thyroid Hormone Resistance Syndrome | 3.3% |
| 405 | Abruptio Placentae | 3.3% |
| 406 | Placenta Accreta | 3.3% |
| 407 | Sebaceous Gland Neoplasms | 3.3% |
| 408 | Spinal Neoplasms | 3.3% |
| 409 | Bone Marrow Neoplasms | 3.3% |
| 410 | Meningeal Neoplasms | 3.3% |
| 411 | Hodgkin Disease | 3.3% |
| 412 | Lymphoma, Non-Hodgkin | 3.3% |
| 413 | Leukemia, Myelomonocytic, Chronic | 3.3% |
| 414 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 3.3% |
| 415 | Myelitis, Transverse | 3.3% |
| 416 | Fetal Diseases | 3.2% |
| 417 | Pregnancy Complications, Cardiovascular | 3.2% |
| 418 | Chorioamnionitis | 3.1% |
| 419 | Pregnancy Complications, Hematologic | 3.1% |
| 420 | Pregnancy Complications, Infectious | 3.1% |
| 421 | Fetal Death | 3.1% |
| 422 | Perinatal death | 3.1% |
| 423 | Morning Sickness | 3% |
| 424 | Nasopharyngeal carcinoma | 3% |
| 425 | Cystitis | 3% |
| 426 | Hydronephrosis | 3% |
| 427 | Hyperoxaluria | 3% |
| 428 | Kidney Cortex Necrosis | 3% |
| 429 | Kidney Papillary Necrosis | 3% |
| 430 | Nephritis | 3% |
| 431 | Nephrosclerosis | 3% |
| 432 | Nephrosis | 3% |
| 433 | Perinephritis | 3% |
| 434 | Kidney Failure | 3% |
| 435 | Uremia | 3% |
| 436 | Ureteral obstruction | 3% |
| 437 | Ureterocele | 3% |
| 438 | Urethral Obstruction | 3% |
| 439 | Urethritis | 3% |
| 440 | Vesico-Ureteral Reflux | 3% |
| 441 | Urinary Retention | 3% |
| 442 | Oxalosis | 3% |
| 443 | Renal Insufficiency | 3% |
| 444 | Mastocytoma | 3% |
| 445 | Meningeal Carcinomatosis | 3% |
| 446 | Mastocytosis, Systemic | 3% |
| 447 | Leukemia, Myeloid, Chronic-Phase | 3% |
| 448 | Kidney Calculi | 2.9% |
| 449 | Ureteral Calculi | 2.9% |
| 450 | Chlamydia Infections | 2.9% |
| 451 | Gonorrhea | 2.9% |
| 452 | Primary amyloidosis | 2.9% |
| 453 | Pituitary Apoplexy | 2.8% |
| 454 | Ear Neoplasms | 2.8% |
| 455 | Eyelid Neoplasms | 2.8% |
| 456 | Lung Neoplasms | 2.8% |
| 457 | Pleural Neoplasms | 2.8% |
| 458 | Diabetic Foot | 2.8% |
| 459 | Mastocytosis | 2.8% |
| 460 | Sturge-Weber Syndrome | 2.8% |
| 461 | Puerperal Infection | 2.8% |
| 462 | Cell Transformation, Viral | 2.8% |
| 463 | Brain Neoplasms | 2.8% |
| 464 | Postpartum Hemorrhage | 2.8% |
| 465 | Salivary Gland Neoplasms | 2.8% |
| 466 | Spinal Cord Neoplasms | 2.8% |
| 467 | Tongue Neoplasms | 2.8% |
| 468 | Gastrointestinal Stromal Tumors | 2.8% |
| 469 | Hemangioma, Cavernous | 2.8% |
| 470 | Leukemia, T-Cell | 2.7% |
| 471 | Leukemia, B-Cell | 2.7% |
| 472 | neurofibroma | 2.7% |
| 473 | Lymphoma, Follicular | 2.7% |
| 474 | T-Cell Lymphoma | 2.7% |
| 475 | Mantle cell lymphoma | 2.7% |
| 476 | Addison Disease | 2.7% |
| 477 | Diabetic Angiopathies | 2.7% |
| 478 | Autoimmune thyroiditis | 2.7% |
| 479 | Primary Adrenal Insufficiency | 2.7% |
| 480 | Diabetic Neuropathies | 2.7% |
| 481 | Myxedema | 2.7% |
| 482 | Diabetic Amyotrophy | 2.7% |
| 483 | Diabetic Autonomic Neuropathy | 2.7% |
| 484 | Diabetic Cardiomyopathies | 2.7% |
| 485 | Hyperprolactinemia | 2.6% |
| 486 | Syphilis | 2.5% |
| 487 | Hepatorenal Syndrome | 2.5% |
| 488 | Bronchial Neoplasms | 2.5% |
| 489 | Bacteriuria | 2.5% |
| 490 | Glycosuria | 2.5% |
| 491 | Hematuria | 2.5% |
| 492 | Renal hypertension | 2.5% |
| 493 | Oliguria | 2.5% |
| 494 | Polyuria | 2.5% |
| 495 | Proteinuria | 2.5% |
| 496 | Pyuria | 2.5% |
| 497 | Renal Artery Obstruction | 2.5% |
| 498 | Renal Artery Stenosis | 2.5% |
| 499 | Urinary Calculi | 2.5% |
| 500 | Hyperglycemic Hyperosmolar Nonketotic Coma | 2.5% |
| 501 | Hashimoto Disease | 2.5% |
| 502 | Multiple Pulmonary Nodules | 2.5% |
| 503 | Cystocele | 2.5% |
| 504 | Nephrocalcinosis | 2.5% |
| 505 | Urinary Incontinence | 2.5% |
| 506 | Supratentorial Neoplasms | 2.5% |
| 507 | Renal Osteodystrophy | 2.4% |
| 508 | Renal rickets | 2.4% |
| 509 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2.4% |
| 510 | Leukemia, Large Granular Lymphocytic | 2.4% |
| 511 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2.4% |
| 512 | Pharyngeal Neoplasms | 2.4% |
| 513 | Xeroderma Pigmentosum | 2.4% |
| 514 | Pyelocystitis | 2.4% |
| 515 | Lymphoma, T-Cell, Cutaneous | 2.4% |
| 516 | Lymphoma, AIDS-Related | 2.4% |
| 517 | Enteropathy-Associated T-Cell Lymphoma | 2.4% |
| 518 | Primary Effusion Lymphoma | 2.4% |
| 519 | Central Nervous System Cysts | 2.4% |
| 520 | Bile Duct Neoplasms | 2.4% |
| 521 | gallbladder neoplasm | 2.4% |
| 522 | Intestinal Neoplasms | 2.4% |
| 523 | Penile Neoplasms | 2.4% |
| 524 | Prostatic Neoplasms | 2.4% |
| 525 | Stomach Neoplasms | 2.4% |
| 526 | Dupuytren Contracture | 2.4% |
| 527 | Polycythemia Vera | 2.3% |
| 528 | Urticaria Pigmentosa | 2.3% |
| 529 | Brain Stem Neoplasms | 2.3% |
| 530 | Mycosis Fungoides | 2.3% |
| 531 | Lymphomatoid Papulosis | 2.3% |
| 532 | Plasmablastic lymphoma | 2.3% |
| 533 | Choroid Plexus Papilloma | 2.2% |
| 534 | Gigantism | 2.2% |
| 535 | Waldenstrom Macroglobulinemia | 2.2% |
| 536 | Multiple Myeloma | 2.2% |
| 537 | Acromegaly | 2.2% |
| 538 | Diabetic Ketoacidosis | 2.2% |
| 539 | Enuresis | 2.2% |
| 540 | Laryngeal neoplasm | 2.2% |
| 541 | Hypopharyngeal Neoplasms | 2.1% |
| 542 | Pleural Effusion, Malignant | 2.1% |
| 543 | Hypopharyngeal Cancer | 2.1% |
| 544 | Lymphogranuloma Venereum | 2.1% |
| 545 | Parotid Neoplasms | 2.1% |
| 546 | Prostatic Neoplasms, Castration-Resistant | 2.1% |
| 547 | Abortion, Habitual | 2.1% |
| 548 | Dystocia | 2.1% |
| 549 | Eclampsia | 2.1% |
| 550 | Fetal Membranes, Premature Rupture | 2.1% |
| 551 | Placental Insufficiency | 2.1% |
| 552 | Pre-Eclampsia | 2.1% |
| 553 | Prenatal Exposure Delayed Effects | 2.1% |
| 554 | HELLP Syndrome | 2.1% |
| 555 | Placenta, Retained | 2.1% |
| 556 | Pyelonephritis | 2.1% |
| 557 | Zollinger-Ellison syndrome | 2% |
| 558 | Tonsillar Neoplasms | 2% |
| 559 | Cerebellar Neoplasms | 2% |
| 560 | Glomerulonephritis | 2% |
| 561 | Nephritis, Interstitial | 2% |
| 562 | Lipoid nephrosis | 2% |
| 563 | Nephrotic Syndrome | 2% |
| 564 | Pyelitis | 2% |
| 565 | Pyonephrosis | 2% |
| 566 | Urethral Stenosis | 2% |
| 567 | Nephrogenic Diabetes Insipidus | 2% |
| 568 | Congenital Nephrogenic Diabetes Insipidus | 2% |
| 569 | Acute kidney injury | 2% |
| 570 | Urethral stricture | 2% |
| 571 | Glycosuria, Renal | 2% |
| 572 | AIDS-Associated Nephropathy | 1.9% |
| 573 | Cecal Neoplasms | 1.8% |
| 574 | Duodenal Neoplasms | 1.8% |
| 575 | Burkitt Lymphoma | 1.8% |
| 576 | Abortion, Veterinary | 1.7% |
| 577 | Pregnancy Complications, Parasitic | 1.7% |
| 578 | Sezary Syndrome | 1.7% |
| 579 | Appendiceal Neoplasms | 1.7% |
| 580 | Colonic Neoplasms | 1.7% |
| 581 | Rectal Neoplasms | 1.7% |
| 582 | Diabetic Retinopathy | 1.7% |
| 583 | Lactation Disorder | 1.7% |
| 584 | Mastitis | 1.7% |
| 585 | Depression, Postpartum | 1.7% |
| 586 | Embryo Loss | 1.7% |
| 587 | Azotemia | 1.7% |
| 588 | Fetal Resorption | 1.7% |
| 589 | Nasopharyngeal Neoplasms | 1.7% |
| 590 | Hyperemesis Gravidarum | 1.7% |
| 591 | Albuminuria | 1.6% |
| 592 | Hemoglobinuria | 1.6% |
| 593 | Hypertension, Renovascular | 1.6% |
| 594 | Urge Incontinence | 1.6% |
| 595 | Colorectal Neoplasms | 1.6% |
| 596 | Paranasal Sinus Neoplasms | 1.5% |
| 597 | Anus Neoplasms | 1.5% |
| 598 | Sigmoid Neoplasms | 1.5% |
| 599 | Balkan Nephropathy | 1.5% |
| 600 | Focal glomerulosclerosis | 1.5% |
| 601 | Kidney Failure, Chronic | 1.5% |
| 602 | Polycystic Kidney Diseases | 1.4% |
| 603 | Fetal Growth Retardation | 1.4% |
| 604 | Diurnal Enuresis | 1.4% |
| 605 | Renal Aminoacidurias | 1.4% |
| 606 | Fanconi Syndrome | 1.4% |
| 607 | Pseudohypoaldosteronism | 1.4% |
| 608 | Liddle Syndrome | 1.4% |
| 609 | Embolism, Amniotic Fluid | 1.4% |
| 610 | Fetal Hypoxia | 1.4% |
| 611 | Fetal Alcohol Spectrum Disorders | 1.4% |
| 612 | Hemolytic-Uremic Syndrome | 1.4% |
| 613 | Maxillary Sinus Neoplasms | 1.4% |
| 614 | Breech Presentation | 1.4% |
| 615 | Stillbirth | 1.4% |
| 616 | Glomerulonephritis, Membranoproliferative | 1.3% |
| 617 | Premature Birth | 1.2% |
| 618 | Renal tubular acidosis | 1.2% |
| 619 | Zellweger Syndrome | 1.1% |
| 620 | Waterhouse-Friderichsen Syndrome | 1.1% |
| 621 | Meconium Aspiration Syndrome | 1.1% |
| 622 | Anti-Glomerular Basement Membrane Disease | 1.1% |
| 623 | Lupus Nephritis | 1.1% |
| 624 | Polycystic Kidney, Autosomal Dominant | 1% |
| 625 | Cystinuria | 1% |
| 626 | Atypical Hemolytic Uremic Syndrome | 1% |
| 627 | Galactorrhea | 1% |
| 628 | Hyperphosphaturia | 1% |
| 629 | Adrenoleukodystrophy | 0.7% |
| 630 | Hydrops Fetalis | 0.5% |
| 631 | Familial Hypophosphatemic Rickets | 0.5% |